|Project Title||Opioid Tolerance and Urine Drug Testing among Initiates of Extended-Release or Long-Acting Opioids in Food and Drug Administration's Sentinel System|
Monday, November 20, 2017
A risk evaluation and mitigation strategy for extended-release and long-acting (ER/LA) opioid analgesics was approved by the Food and Drug Administration in 2012. The authors' objective was to assess frequency of opioid tolerance and urine drug testing for individuals initiating ER/LA opioid analgesics.
extended-release and long-acting (ER/LA) opioid analgesic
|Population / Cohort|
All individuals 0-64 years of age
January 1, 2009 – December 31, 2013
Mini-Sentinel Distributed Database (MSDD)